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UNIT A7.7Lymph Node Staging in the Neck
Examination of the anatomy and pathology of the lymph nodes of the neck as seen by
magnetic resonance imaging (MRI) shows a wide variety of findings and thereby presents
a challenging task for the radiologist. Patients with a broad range of clinical presentations
and disease states are imaged with MRI due to its rapidly evolving improvements in spatial
and contrast resolution, the reduction of artifacts with this technique, and the development
of new contrast agents (van den Brekel, 2000).
Although the reasons for performing MRI are numerous, the MR imaging sequences and
protocols for the evaluation of lymph nodes are straightforward and allow initial staging
of disease and evaluation of the success of therapy.
BASIC
PROTOCOL
IMAGING OF THE LYMPH NODES USING MRI
Magnetic resonance imaging scans can be performed at a range of field strengths. In
general, the high signal-to-noise ratio (SNR) obtained at high field strengths allows one
to scan either faster or with higher resolution compared to lower field strengths. The
sequences described within this unit are based on the authors’ experience using a Siemens
1.5 T Symphony scanner, but are expected to be equally applicable to scanners from other
manufacturers.
Scanning a patient or volunteer is a team effort of the technologists, nurses, and physi-
cians. In most cases, the technologist assumes the lead role in acquiring the appropriate
images.
The set of sequences described in the following protocol comprises the preferred
method of imaging the soft tissues of the neck. The usual sequences employed include
transverse T1-weighted spin echo and fast spin-echo (FSE) or turbo spin-echo (TSE)
fat-saturated T2-weighted images acquired prior to contrast administration. Contrast
enhancement is necessary to assess the extent of any metastatic spread and to
determine if the cancerous or diseased lymph node has infiltrated any adjacent
structures, most importantly arteries and veins, as well as adjacent nerves. In addition,
a better distinction of cystic lesions and abscesses can often be achieved, compared
to non-contrast examinations.
All of the sequences in this protocol are non-breath-hold examinations; however, the
patient should be advised not to swallow or move his or her head while the sequences
are running. The duration for the imaging process, including all preparations, is ∼30
min.
Table A7.7.1 lists the hardware necessary to perform the procedure along with appropriate
parameters. The available gradient strength will depend on the scanner, and the echo times
given later in other tables will have to be varied accordingly (the smaller the gradient
strength, the longer the echo time for a particular scan).
NOTE: Be sure that technologists and nurses have immediate access to any emergency
equipment that may be relevant to a given study, or that may be needed for a particular
patient, such as crash carts or oxygen.
Materials
Normal saline (0.9% NaCl), sterile
Gadolinium-based MR contrast agent (e.g., Magnevist, Omniscan, or Prohance)
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Set up patient and equipment
1. Interview the patient to ensure that he or she has no contraindication such as cardiac
pacemakers or other implants containing ferromagnetic materials. Also, be sure to
find out if the patient has any health conditions that may require the presence of
special emergency equipment during the scanning procedure, or that might necessi-
tate any other precautions.
Generally, standard screening forms (APPENDIX 1) are used for all patients scanned in a
magnetic resonance system.
The presence of any ferromagnetic metals may be a health hazard to the patient when he
or she is inside the magnet, and will also affect the imaging. If in doubt as to the exact
composition of the items, it is best to exclude patients with any metal implants; see Shellock
and Kanal (1998), Shellock and Crues (1998), and Shellock and Shellock (1998) for
discussion of what implants may be safely scanned using magnetic resonance.
Patients may be accompanied into the magnet room by a friend or family member who can
sit in the room during the scan and comfort the patient as needed. This companion must
be screened as well to ensure the absence of loose metal objects on the body or clothing.
2. If the procedure is a research protocol, have the patient sign any necessary consent
forms.
3. Have the patient remove all jewelry and change into a gown to eliminate any metal
that might be found in the clothing.
4. Have the patient wash off any mascara and other makeup to avoid local tissue heating
and image artifacts.
5. Inform the patient about what will occur during the procedure, what he or she will
experience while in the magnet, as well as how to behave. Issues to discuss include
the following:
a. If earphones or headphones are used to protect the ears from the loud sounds
produced by the gradients, the patient will be asked to wear these, but will be able
to communicate with you at any time during the imaging.
b. The patient will be given a safety squeeze-bulb or similar equipment to request
assistance at any time (demonstrate how this works).
c. For optimum results, the patient should not talk, and should avoid or minimize
swallowing or other movement during each scan—i.e., as long as the banging
sounds continue. Between scans, talking and swallowing are allowed in most
cases, but should be avoided when comparative positional studies are being
performed; the patient will be informed when this is the case.
d. Nevertheless, the patient may call out at any time if he or she feels it is necessary.
Table A7.7.1 Equipment Parameters
Coil type Circularly polarized head coil (or
phased-array neck coil, if available)
Gradient coil strength 30 mT/m (or whatever the system permits)
Cardiac gating No
Peripheral gating For safety only
Respiratory gating No
Respirator If required by patient
Oxygen If required by patient
Motion cushions Useful
Use of contrast agents Necessary
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6. Have the patient climb onto the table. Either before or right after the patient lies down,
set up any triggering devices or other monitoring equipment that is to be used.
7. Establish an intravenous line through which the contrast agent can be injected. Attach
this line securely to the patient so that movement into or out of the magnet will not
pull at the patient’s arm.
It is preferable to insert the line prior to imaging and to leave the patient in the magnet so
that there is no intervening motion between the scans run before contrast agent injection
and those run after injection.
8. Center the patient in a head or neck coil at the region where the key information is
desired. Make sure that the head and neck are constrained to prevent motion,
especially if high-resolution scans are being performed.
Generally, the patient’s head is fixed so that it is horizontal (not tilted) and the neck and
head lie along the long axis of the scanner table. Most scanners have a dedicated neck coil.
9. If needed, place a pillow or other support under the patient’s knees to make him or
her more comfortable.
10. Use the centering light to position the patient’s nasion and put him or her into the
center of the magnet.
Once this step has been performed, so long as the patient does not move on the table, the
table itself can be moved and then replaced in the same position as previously without
jeopardizing the positioning of one scan relative to another (usually to within ±1 mm
accuracy).
11. If the patient is unable to hold still, provide an appropriate sedative.
Sequence 1: The pilot scan
12. To validate the patient’s position, run the system’s pilot scan to ensure the correct
location of the neck in three dimensions, using the imaging parameters given in Table
A7.7.2.
Table A7.7.2 Primary Clinical Imaging Parameters for Sequence 1 (Pilot Scan)
Patient position Supine
Scan type Gradient echo
Imaging plane (orientation) Transverse, coronal, and sagittal
Central slice or volume center Laser light centered on the larynx
Echo time (TE) ≤5 msec
Repeat time (TR) ≤20 msec
Flip angle (FA) 40°
Fields of view (FOVx, FOVy) 256 mm, 160 mm
Resolution (∆x, ∆y) 1.0 mm, 1.0 mm
Number of data points collected (Nx, Ny) 256, 160
Slice thickness (∆z) 5 mm
Number of slices 1 per orientation
Slice gap Not applicable
Number of acquisitions (Nacq) 1
Scan time 9 sec
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Figure A7.7.1 Mass of the oropharynx on transverse T2-weighted, fat-saturated, MR image
(arrowhead). Bilateral normal-sized internal jugular chain lymph nodes (arrows) are visible, without
signs of metastatic spread.
Table A7.7.3 Primary Clinical Imaging Parameters for Sequence 2 (Transverse
T2-Weighted Fat-Saturated TSE)
Patient position Supine
Scan type Turbo spin echo
Imaging plane (orientation) Transverse
Central slice or volume center Epiglottis
Echo time (TE) 71 msec
Echo train length (ETL) 11
Repeat time (TR) 6000 msec
Flip angle (FA) 150°a
Fields of view (FOVx, FOVy) 192 mm, 153 mm
Resolution (∆x, ∆y) 0.75 mm, 0.75 mm
Number of data points collected (Nx, Ny) 256, 204
Slice thickness (∆z) 5 mm
Number of slices 30
Slice gap 1.5 mm
Number of acquisitions (Nacq) 2
Read direction Right–left
Fat suppression Yes
Scan time 233 sec
aThe system displays the flip angle of the refocusing pulse. The flip angle of the first pulse of this sequence
is 90°.
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This sequence usually consists of three orthogonal planes to allow exact localization of the
bilateral cervical lymph nodes. These images are often also used later to determine where
to place the saturation pulses and to confirm total coverage of the volume of interest.
Sequence 2: Transverse T2-weighted, fat-saturated turbo spin echo (TSE)
13. Display the coronal, sagittal, and transverse scout images in split-window mode on
the scan monitor. Change imaging parameters to those listed in Table A7.7.3. Position
the slices to cover the area from the posterior fossa to the thoracic inlet in the coronal
and sagittal planes, as well as the anterior, posterior, and lateral margins of the neck
in the transverse plane. Let the patient know you are ready, and begin the scan.
An example image is shown in Figure A7.7.1.
Figure A7.7.2 Imaging of a normal-sized cervical lymph node (arrow) by a transverse T1-
weighted SE sequence.
Table A7.7.4 Primary Clinical Imaging Parameters for Sequence 3 (T1-Weighted
Transverse)
Patient position Supine
Scan type Spin echo
Imaging plane (orientation) Transverse
Central slice or volume center Epiglottis
Echo time (TE) 12 msec
Repeat time (TR) 660 msec
Flip angle (FA) 90°
Fields of view (FOVx, FOVy) 192 mm, 156 mm
Resolution (∆x, ∆y) 0.75 mm, 0.75 mm
Number of data points collected (Nx, Ny) 256, 208
Slice thickness (∆z) 4 mm
Number of slices 25
Slice gap 1.2 mm
Number of acquisitions (Nacq) 2
Read direction Right–left
Scan time 279 sec
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Figure A7.7.3 Imaging of a normal cervical lymph node (arrow) by a T1-weighted contrast
enhanced, fat-saturated SE sequence.
Table A7.7.5 Primary Clinical Imaging Parameters for Sequence 4 (T1-Weighted
Transverse Fat-Saturated)
Patient position Supine
Scan type Spin echo
Imaging plane (orientation) Transverse
Central slice or volume center Epiglottis
Echo time (TE) 12 msec
Repeat time (TR) 600 msec
Flip angle (FA) 90°
Fields of view (FOVx, FOVy) 192 mm, 156 mm
Resolution (∆x, ∆y) 0.75 mm, 0.75 mm
Number of data points collected (Nx, Ny) 256, 208
Slice thickness (∆z) 5 mm
Number of slices 30
Slice gap 1.5 mm
Number of excitations (NEX) 2a
Number of acquisitions (Nacq) 2
Read direction Right–left
Fat suppression Yes
Scan time 506 sec
aThe number of concatenation is set to be 2. This means that only half of the total slices will be excited
during a given repeat time.
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Sequence 3: Transverse T1-weighted spin echo (SE)
14. Bring the sequence for a T1-weighted SE scan up on the console. Set the imaging
parameters as shown in Table A7.7.4.
15. Use the History function to select slice positions from the previous sequence,
Sequence 2 (T2-weighted, transverse, fat-saturated TSE). Let the patient know you
are ready, and begin the scan.
An example image is shown in Figure A7.7.2.
Sequence 4: Transverse T1-weighted, fat saturated spin echo (SE), post-contrast
16. Copy the slice parameters, such as number of slices, field of view, dimension of slices,
and center of slices from the performed T1-transverse sequence 3 and change the
imaging parameters to those listed in Table A7.7.5.
17. Before proceeding, administer the contrast agent.
A dose of 0.2 mmol/kg gadolinium is usually given at a rate of 1 ml/sec.
18. Wait 3 min before proceeding. Inform the patient of the 3-min delay.
19. Let the patient know you are ready, and begin the scan.
An example image is shown in Figure A7.7.3.
20. Take the patient out of the magnet.
COMMENTARY
Background Information
Imaging may be performed for the evalu-
ation of any unknown neck mass, but the use
of imaging to detect and evaluate primary or
metastatic malignancy within lymph nodes is
common in the diagnosis and staging of head
and neck disease (Sakai et al., 2000). In chil-
dren, lymphadenopathy is the most common
solid neck mass, with lymphoma ranking third
among all the solid neck masses occurring in
childhood. In adults in the United States, lym-
phoma represents the seventh leading cause of
cancer deaths (Daehnert, 1999).
Unreliable criteria for differentiating benign
from malignant causes of lymphadenopathy,
such as increased anteroposterior diameter,
prominent calcifications, or marginal contrast
enhancement in computed tomography (CT),
are being replaced by the successful depiction
of the soft tissue microstructure inside the
lymph nodes (van den Brekel et al., 1996) by
means of MR imaging.
The evolving improvements in spatial reso-
lution, the reduction of artifacts, and the devel-
opment of new contrast agents allow anatomi-
cal visualization to precisely assess the extent
of any cancerous spread or infiltration into
adjacent structures, most importantly arteries
or veins, as well as into adjacent nerves. These
routes of extranodal tumor extension are his-
tologically found in 40% of lymph nodes with
diameters less than 2 cm, which would thereby
be considered normal by size criteria (Cum-
mings, 1993). In 75% of lymph nodes larger
than 3 cm, extranodal tumor spread is present.
Furthermore MR imaging has the potential
to precisely show anatomic landmarks that
make nodal levels reproducible. The lymph
nodes in the neck are divided into seven specific
anatomic subsites. The level concept is driven
by the fact that the extent and level of cervical
node involvement by metastatic tumor is prog-
nostically important (Harnsberger, 1995; Fig.
A7.7.4).
The imaging findings complement the
physical examination, and the imaging-based
classification provides the radiologist with
clinically acceptable guidelines for classifying
the cervical nodes and communicating the find-
ings to clinicians (Som et al., 2000).
The most common indication for perform-
ing MRI of the soft tissue of the neck in adults
is a strong suspicion or staging of head and neck
cancer, especially carcinomas of the upper
aerodigestive tract (Lenz et al., 1993). In addi-
tion to metastatic squamous carcinoma of the
upper aerodigestive tract, the differential diag-
nosis of enlarged cervical lymph nodes also
includes the lymphatico-lymphatic spread as
well as the metastatic dispersion via lympha-
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tico-venous pathways. If cancer cells invade the
reticular and medullary tissue of the lymphatic
nodes, a blockage of the lymph flow occurs,
leading to an increase of interstitial fluid. Vary-
ing amounts of interstitial fluid and infiltrated
medullary meshwork results in variable MR
appearances; however, lymph nodes such as
these are all typically referred to as necrotic
(Som, 1987).
Infections of bacterial, mycobacterial, or
viral cause are other common reasons for lym-
phadenopathy. Further indications are granu-
lomatous conditions such as sarcoidosis, as
well as primary and secondary involvement in
lymphoma, e.g., Hodgkin’s as well as non-
Hodgkin’s lymphomas. Other metastatic neo-
plasms originating from breast and lung are
also common causes of diffuse metastatic en-
largement of cervical lymph nodes. Conditions
such as sinus histiocytosis and eosinophilic
granuloma also occasionally occur (Kaji et al.,
1997).
In addition, MR imaging can be utilized for
percutaneous MRI-guided biopsies of lymph
nodes, using dedicated open scanners accom-
panied by the development of fast gradient echo
pulse sequences to secure the diagnosis by
histology (Lewin et al., 2000).
Critical Parameters and
Troubleshooting
The high magnetic field strength of 1.5 T
magnets and T1-weighted spin echo sequences
with fat saturation and contrast enhancement,
as well as T2-weighted fast spin echo or turbo
spin echo techniques, reveal a remarkably in-
tense and precise signal from the lymph nodes.
High spatial resolution is desired so that
small areas of signal variation are not missed.
The exact anatomical visualization of arteries
and veins, as well as of neural structures such
as the cervical and brachial plexus, allows a
precise diagnosis of whether any cancerous
formation has invaded those organs, which are
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Figure A7.7.4 Seven anatomic subsites of lymph nodes in the neck. Level I contains the submen-
tal and the submandibular nodes. Level II includes the upper deep cervical chain nodes. Level III
includes the middle deep cervical chain nodes, and analogous Level IV includes the lower deep
cervical chain nodes. Level V comprises the spinal accessory nodes and the transverse cervical
chain nodes. Level VI contains the pretracheal, the prelaryngeal, and the paratracheal nodes. In
Level VII the upper mediastinal lymph nodes can be found. Figure is based on Harnsberger (1995).
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most vulnerable to the spread of cancer. More-
over, it is important to center the planes in order
to perform a comparison with the opposite side
of the neck, to identify any area of abnormality,
and to differentiate between pathology and ana-
tomical variation.
Anticipated Results
A variety of findings concerning the lymph
nodes is possible utilizing magnetic resonance
imaging. To ensure that the complete anatomi-
cal region containing the cervical lymph path-
ways is imaged, the neck should be visualized
from the skull base to the thoracic inlet, thereby
clearly indicating the body of the hyoid bone,
the cricoid arch, the top of the manubrium, and
the back edge of the submandibular gland as
important landmarks. Posteriorly, the back
edge of the sternocleidomastoid muscle, the
lateral posterior edge of the anterior scalene
muscle, and the anterior edge of the trapezius
muscle should be included in the field of view
and should contain both the internal carotid and
common carotid arteries and the internal jugu-
lar vein.
Anteriorly, the clavicle, the medial margin
of the anterior belly of the digastric muscle, and
the mylohoid muscle are utilized as important
landmarks.
Although in most cases a specific diagnosis
can be suggested by other means of visualiza-
tion, only MRI has the potential to demonstrate
the extent of disease with high precision, thanks
to the high spatial resolution, thereby allowing
competitive and comparable MR imaging,
which is crucial to the staging process in esti-
mating the expected success of therapy.
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